• ulcerative colitis market set for robust growth across the 7mm from usd 8.4 billion in 2023 | delveinsight The Globe and Mail Fri, 11 Apr 2025 12:50:00 GMT
• ulcerative colitis drugs market 2034: ema, pdma, fda approvals, clinical trials, medication, therapies, prevalence and companies b... The Globe and Mail Fri, 10 Jan 2025 01:57:29 GMT
• executives on the move: abivax aquires chief medical officer from landos biopharma and gets a new chief strategy officer News & Insights Thu, 18 Jul 2024 07:00:00 GMT
• type 1 diabetes pipeline insights (2024) | clinical trials, latest approvals, treatment options, key companies | landos biopharma,... Barchart Mon, 15 Jul 2024 12:08:00 GMT
• abbvie acquires celsius therapeutics, gains anti-inflammatory disease antibody BioPharm International Fri, 28 Jun 2024 07:00:00 GMT
• AbbVie expands its IBD prospects with $250M Celsius deal BioPharma Dive Thu, 27 Jun 2024 07:00:00 GMT
• landos biopharma reports first quarter 2021 financial results and provides business updates Marketscreener.com Fri, 21 Jun 2024 22:41:17 GMT
• abbvie doubles down on immunology with futuregen licensing deal Finimize Thu, 13 Jun 2024 15:28:18 GMT
• AbbVie inks immune disorder drug licensing deal with China's FutureGen Reuters Thu, 13 Jun 2024 07:00:00 GMT
• abbvie finalizes landos biopharma acquisition by investing.com Investing.com Australia Fri, 24 May 2024 00:56:21 GMT
• kintara therapeutics restructures share designations by investing.com Investing.com Thu, 23 May 2024 07:00:00 GMT
• abbvie finalizes landos biopharma acquisition by investing.com Investing.com Thu, 23 May 2024 07:00:00 GMT
• abbvie completes acquisition of landos biopharma | labp stock news StockTitan Thu, 23 May 2024 07:00:00 GMT
• pharma stock roundup: abbv & nvo's new m&as, fda nod to jnj & mrk pah drugs MSN Fri, 17 May 2024 05:57:13 GMT
• here's why we're not at all concerned with landos biopharma's (nasdaq:labp) cash burn situation Yahoo Canada Shine On Mon, 13 May 2024 10:52:58 GMT
• landos biopharma investor alert by the former attorney general of louisiana: kahn swick & foti, llc ... Barron's Sat, 11 May 2024 07:00:00 GMT
• landos biopharma's latest deal faces tough regulatory gauntlet: hsr act and ftc scrutiny may impose delays ... TipRanks Fri, 10 May 2024 06:04:27 GMT
• 5 biotech stocks set to outpace q1 earnings estimates Yahoo Movies UK Fri, 10 May 2024 04:00:30 GMT
• why is ulcerative colitis-focused landos biopharma stock trading higher on monday? MSN Mon, 06 May 2024 14:58:05 GMT
• landos biopharma reports third quarter 2021 financial results and provides corporate update Barchart Sun, 05 May 2024 16:39:09 GMT
• ex-humira growth platform drives abbvie's q1 performance, drugmaker lifts annual profit outlook - abbvie (nyse ... Benzinga Fri, 26 Apr 2024 07:00:00 GMT
• shareholder investigation: halper sadeh llc investigates alpn, labp, swav, fusn AccessWire Mon, 22 Apr 2024 22:52:08 GMT
• AbbVie tops, J&J drops as physicians rank immunology players Fierce Pharma Fri, 19 Apr 2024 07:00:00 GMT
• stockholder alert: ademi llp continues investigation of the fairness of landos biopharma, inc.'s transaction with abbvie Morningstar Tue, 16 Apr 2024 07:00:00 GMT
• service-stockholder alert: ademi llp continues investigation of the fairness of landos ... IANS India Pvt Ltd Tue, 16 Apr 2024 07:00:00 GMT
• abbvie to acquire landos biopharma and novel ulcerative colitis investigational drug Managed Healthcare Executive Tue, 09 Apr 2024 07:00:00 GMT
• research analysts set expectations for landos biopharma, inc.'s q1 2024 earnings (nasdaq:labp) Defense World Thu, 04 Apr 2024 07:00:00 GMT
• landos biopharma, inc. to post q1 2024 earnings of ($0.88) per share, hc wainwright forecasts (nasdaq:labp) MarketBeat Wed, 03 Apr 2024 14:48:45 GMT
• q1 2024 earnings forecast for landos biopharma, inc. (nasdaq:labp) issued by hc wainwright MarketBeat Wed, 03 Apr 2024 14:46:35 GMT
• equities analysts offer predictions for landos biopharma, inc.'s q1 2024 earnings (nasdaq:labp) MarketBeat Wed, 03 Apr 2024 10:01:58 GMT
• landos biopharma, inc. expected to earn q1 2024 earnings of ($0.88) per share (nasdaq:labp) MarketBeat Wed, 03 Apr 2024 10:01:58 GMT
• hc wainwright reiterates neutral rating for landos biopharma (nasdaq:labp) Defense World Wed, 03 Apr 2024 07:00:00 GMT
• landos biopharma (nasdaq:labp) earns neutral rating from hc wainwright MarketBeat Mon, 01 Apr 2024 12:31:58 GMT
• landos biopharma (nasdaq:labp) rating reiterated by hc wainwright MarketBeat Mon, 01 Apr 2024 12:31:58 GMT
• hc wainwright reiterates neutral rating for landos biopharma (nasdaq:labp) MarketBeat Mon, 01 Apr 2024 12:31:58 GMT
• this biopharma stock outperformed mstr and smci in march 2024 TipRanks Mon, 01 Apr 2024 10:02:09 GMT
• landos biopharma stock downgraded at h.c. wainwright amid abbvie acquisition Investing.com Mon, 01 Apr 2024 07:00:00 GMT
• wedbush sees 15% upside left for nasdaq, tech stocks by investing.com Investing.com India Mon, 01 Apr 2024 07:00:00 GMT
• zuu co. ltd. executives purchase pono capital two shares worth $390 by investing.com Investing.com Mon, 01 Apr 2024 07:00:00 GMT
• allied gaming executive choi buys shares worth $778k by investing.com Investing.com Mon, 01 Apr 2024 07:00:00 GMT
• brodsky & smith shareholder update: notifying investors of the following investigations: adtheorent ... GlobeNewswire Mon, 01 Apr 2024 07:00:00 GMT
• the week in pharma: action, reaction and insight – week to march 29, 2024 The Pharma Letter Sun, 31 Mar 2024 07:00:00 GMT
• focus on - european medicines agency, abbvie, landos biopharma The Pharma Letter Sun, 31 Mar 2024 07:00:00 GMT
• ers international congress 2016 - landos biopharma, respiratory and pulmonary The Pharma Letter Sun, 31 Mar 2024 07:00:00 GMT
• pharma stock roundup: abbv & nvo's new m&as, fda nod to jnj & mrk pah drugs Yahoo Finance Thu, 28 Mar 2024 07:00:00 GMT
• Opinion: AbbVie-Landos Deal Signals Continued Momentum for Next-Gen I&I Drugs BioSpace Wed, 27 Mar 2024 07:00:00 GMT
• abbvie acquires landos biopharma and gets full fda nod for adc product BioPharm International Wed, 27 Mar 2024 07:00:00 GMT
• abbvie to expand inflammatory and autoimmune disease portfolio with $212.5m landos acquisition PMLiVE Wed, 27 Mar 2024 07:00:00 GMT
• abbvie acquisition signals confidence in small-cap biotech sector’s growth potential Proactive Investors Australia Wed, 27 Mar 2024 07:00:00 GMT
• abbvie pumps up autoimmune portfolio by acquiring landos Inside Precision Medicine Wed, 27 Mar 2024 07:00:00 GMT
• landos biopharma investor alert by the former attorney general of louisiana: kahn swick & foti, llc ... Business Wire Wed, 27 Mar 2024 07:00:00 GMT
• critical contrast: sunshine biopharma (nasdaq:sbfm) & landos biopharma (nasdaq:labp) Defense World Wed, 27 Mar 2024 07:00:00 GMT
• abbvie to acquire landos biopharma for $20.42 per share in cash plus cvr - tipranks.com TipRanks Tue, 26 Mar 2024 12:40:09 GMT
• abbvie to acquire landos biopharma got $20.42 per share in cash TipRanks Tue, 26 Mar 2024 12:40:05 GMT
• AbbVie signs agreement to acquire Landos Biopharma for $212.5m Pharmaceutical Technology Tue, 26 Mar 2024 07:00:00 GMT
• abbvie (abbv) to buy landos to strengthen autoimmune portfolio Yahoo Finance Tue, 26 Mar 2024 07:00:00 GMT
• abbvie to bolster immunity illness drug pipeline with landos deal ETHealthWorld Tue, 26 Mar 2024 07:00:00 GMT
• stockholder investigation: the m&a class action firm announces an investigation of landos biopharma, inc - labp PR Newswire Tue, 26 Mar 2024 07:00:00 GMT
• abbvie acquisition signals confidence in small-cap biotech sector's growth potential Proactive Investors USA Tue, 26 Mar 2024 07:00:00 GMT
• abbvie to acquire landos biopharma for $137.5 million by investing.com Investing.com Australia Tue, 26 Mar 2024 02:49:29 GMT
• abbvie gets another ulcerative colitis contender via $137m landos acquisition MedCity News Tue, 26 Mar 2024 00:22:30 GMT
• novo, abbvie, lonza boost portfolios, manufacturing as part of 2024 m&a upswing BioSpace Mon, 25 Mar 2024 21:32:22 GMT
• investigation alert: halper sadeh llc investigates labp, fusn, knte Marketscreener.com Mon, 25 Mar 2024 19:30:03 GMT
• abbvie to buy landos biopharma - chicago business journal The Business Journals Mon, 25 Mar 2024 16:39:00 GMT
• landos biopharma's definitive merger with abbvie subsidiary - tipranks.com TipRanks Mon, 25 Mar 2024 13:18:09 GMT
• abbvie to buy landos to expand pipeline of immunity-related illnesses Marketscreener.com Mon, 25 Mar 2024 12:37:25 GMT
• AbbVie Acquires Landos in Potential $212M Deal, Bolsters Anti-Inflammatory Pipeline BioSpace Mon, 25 Mar 2024 07:00:00 GMT
• AbbVie grabs a wrench to add immunology-focused Landos Biopharma for $137.5M Fierce Biotech Mon, 25 Mar 2024 07:00:00 GMT
• AbbVie to bolster immunity illness drug pipeline with Landos deal Reuters Mon, 25 Mar 2024 07:00:00 GMT
• AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases PR Newswire Mon, 25 Mar 2024 07:00:00 GMT
• In small acquisition, AbbVie adds Landos and its IBD drug to post-Humira plans Endpoints News Mon, 25 Mar 2024 07:00:00 GMT
• AbbVie Gets Another Ulcerative Colitis Contender via $137M Landos Acquisition MedCity News Mon, 25 Mar 2024 07:00:00 GMT
• abbvie keeps up acquisition spree, this time for an immunology-focused startup Crain's Chicago Business Mon, 25 Mar 2024 07:00:00 GMT
• shareholder alert: ademi llp investigates whether landos biopharma, inc. has obtained a fair price in its transaction with abbvie PR Newswire Mon, 25 Mar 2024 07:00:00 GMT
• why landos biopharma shares are trading higher by over 170%? here are other stocks moving in monday's mid-day session by benzinga Investing.com UK Mon, 25 Mar 2024 07:00:00 GMT
• why is ulcerative colitis-focused landos biopharma stock trading higher on monday? Yahoo Finance Mon, 25 Mar 2024 07:00:00 GMT
• landos biopharma’s definitive merger with abbvie subsidiary TipRanks Mon, 25 Mar 2024 07:00:00 GMT
• landos shares rocket 170% on abbvie takeover deal (nasdaq:labp) Seeking Alpha Mon, 25 Mar 2024 07:00:00 GMT
• abbvie to buy landos biopharma for $137 million The Business Journals Mon, 25 Mar 2024 07:00:00 GMT
• abbvie to acquire landos biopharma got $20.42 per share in cash TipRanks Mon, 25 Mar 2024 07:00:00 GMT
• brodsky & smith shareholder update: notifying investors of GlobeNewswire Mon, 25 Mar 2024 07:00:00 GMT
• abbvie buys landos for up to $212.5 million | biotechnology | the pharmaletter | the pharmaletter The Pharma Letter Mon, 25 Mar 2024 07:00:00 GMT
• landos biopharma shares surge 178% on takeover deal with abbvie MarketWatch Mon, 25 Mar 2024 07:00:00 GMT
• labp stock alert: halper sadeh llc is investigating whether the sale of landos biopharma, inc. is fair to shareholders Business Wire Mon, 25 Mar 2024 07:00:00 GMT
• what is wall street's target price for landos biopharma inc (labp) stock monday? InvestorsObserver Mon, 25 Mar 2024 07:00:00 GMT
• abbvie to acquire landos biopharma for $137.5 million by investing.com Investing.com Mon, 25 Mar 2024 07:00:00 GMT
• nimml institute's titan-x a.i.-powered precision medicine platform validated through abbvie's acquisition of landos ... Business Wire Mon, 25 Mar 2024 07:00:00 GMT
• crude oil moves higher; us new home sales fall in february Markets Insider Mon, 25 Mar 2024 07:00:00 GMT
• nasdaq turns higher; akanda shares plunge | markets insider Markets Insider Mon, 25 Mar 2024 07:00:00 GMT
• abbvie to acquire landos biopharma for $20.42 per share in cash plus cvr - tipranks.com TipRanks Mon, 25 Mar 2024 07:00:00 GMT
• this biopharma stock outperformed mstr and smci in march 2024 - tipranks.com TipRanks Mon, 25 Mar 2024 07:00:00 GMT
• abbvie inc. agreed to acquire landos biopharma, inc. on march 24, 2024. Marketscreener.com Sun, 24 Mar 2024 23:00:00 GMT
• will landos biopharma (nasdaq:labp) spend its cash wisely? Simply Wall St Sat, 23 Mar 2024 06:50:16 GMT
• will landos biopharma (nasdaq:labp) spend its cash wisely? Simply Wall St Fri, 22 Mar 2024 07:00:00 GMT
• landos biopharma, inc. reports earnings results for the full year ended december 31, 2023 Marketscreener.com Thu, 21 Mar 2024 12:34:00 GMT
• landos biopharma provides business update and reports fourth quarter and full year 2023 results GlobeNewswire Thu, 21 Mar 2024 07:00:00 GMT
• labp stock earnings: landos biopharma misses eps for q4 2023 InvestorPlace Thu, 21 Mar 2024 07:00:00 GMT
• how will the market react to landos biopharma inc (labp) stock getting a bullish rating InvestorsObserver Tue, 19 Mar 2024 14:02:44 GMT
• will landos biopharma (nasdaq:labp) spend its cash wisely? Yahoo Finance Tue, 05 Mar 2024 08:00:00 GMT
• ulcerative colitis market to advance at moderate cagr during the forecast period (2023-32) - estimates delveinsight ... openPR Tue, 20 Feb 2024 08:00:00 GMT
• fy2024 eps estimates for landos biopharma, inc. lifted by analyst (nasdaq:labp) Defense World Fri, 09 Feb 2024 09:13:29 GMT
• landos biopharma, inc. (nasdaq:labp) expected to earn q1 2024 earnings of ($1.12) per share Defense World Fri, 09 Feb 2024 07:46:53 GMT
• landos biopharma inc annual shareholders meeting transcript GuruFocus.com Thu, 08 Feb 2024 03:42:05 GMT
• landos biopharma to present new data on immunometabolism at the 19th annual congress of the european crohn's ... Yahoo Finance Mon, 08 Jan 2024 08:00:00 GMT
• y-mabs therapeutics (nasdaq:ymab) & landos biopharma (nasdaq:labp) financial comparison Defense World Mon, 18 Dec 2023 06:28:53 GMT
• virtual drug screening system market analysis |huawei, aria ... Argyle Report Tue, 05 Dec 2023 18:56:06 GMT
• ulcerative colitis pipeline, fda approvals, clinical trials developments, and companies 2023 openPR Tue, 05 Dec 2023 10:43:00 GMT
• landos biopharma earnings beat by $0.01, revenue was in line with estimates Investing.com Nigeria Tue, 05 Dec 2023 08:00:00 GMT
• is landos biopharma inc (labp) stock a bad value wednesday? InvestorsObserver Wed, 29 Nov 2023 08:00:00 GMT
Landos Biopharma, Inc(NASDAQ:LABP) 
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. Its lead product candidate in development is BT-11, an oral lanthionine synthetase C-like protein 2 (LANCL2) agonist for the treatment of ulcerative col...
Website: http://landosbiopharma.com
Founded: 2017
CEO: Josep Bassaganya-Riera
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends